In a pioneering collaboration aimed at transforming pediatric cancer diagnostics and research, Boston Children’s Hospital, Dana-Farber Cancer Institute, and Broad Clinical Labs have announced the formation of BrightSeq–Boston Research in Innovative Genomics for Hematologic and Tumor Sequencing – collaborative clinical research and testing initiative.
